Transition from the STED Format to the IMDRF-ToC Template for Submission of Technical Documents to Support the Registration of Medical Devices
The National Agency for Food and Drug Administration and Control (NAFDAC) was formally accepted by the International Medical Device Regulators Forum (IMDRF) as an Affiliate Member on the 22nd of March 2024. The IMDRF is a voluntary group of global medical device regulators worldwide who have come together to accelerate international medical device harmonization and […]
Report Of Risk-Based Post-Market Surveillance Of Selected Medical Products In Nigeria Carried Out In 2021, 2022 & 2023.
Was this helpful? Yes No Submit Cancel Thanks for your feedback!
International Council for Harmonization (ICH) Q1 Stability Guideline Workshop
Executive Summary for International Council for Harmonization (ICH) Q1 Stability Guideline Workshop Overview:The International Council for Harmonization (ICH) Q1 workshop was organized by the National Agency for Food and Drug Administration and Control (NAFDAC) supported by Northeastern University Boston USA and ICH, was held from 22nd-24th July 2024 at the Marriot Hotels Ikeja Lagos. The […]
International Council for Harmonization (ICH) Q7 (Good Manufacturing Practice Guideline for Active Pharmaceutical Ingredients) Training for Regulators and Industry
Executive Summary of the International Council for Harmonization (ICH) Q7 (Good Manufacturing Practice Guideline for Active Pharmaceutical Ingredients) Training for Regulators and Industry The recently concluded ICH Q7 training program, organized by NAFDAC and the Northeastern University Boston USA which was held from the 25th-26th July 2024, it successfully brought together regulators, industry professionals, academia […]
Public Alert No. 038/2024 -Alert on Recall of Cardura XL (Doxazosin) Extended-Release Tablets
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the recall of two (2) lots of a hypertension drug, Cardura XL (Doxazosin) extended-release tablets (8mg & 4mg), manufactured by American global pharmaceutical and healthcare company, Viatris Inc., with lot numbers 81470418163765 and 81470408163764. These drug lots are being […]
Illegal Production, Sale and Advertisement of Unregistered, Suspected Unwholesome Miracle Water and Other Brands of the Water, and Miracle Soap by Christ Mercy Land Delivery Ministries, Km 5 Effurun, Sapele Road, Delta State.
The National Agency for Food and Drug Administration and Control (NAFDAC) wishes to alert the public on the activities of a faith-based organization – Christ Mercy Land Delivery Ministries – that uses NAFDAC’s name to deceive unsuspecting public. Recently, NAFDAC have been inundated with petitions from concerned citizens about Senior Prophet Jeremiah Omoto of Christ […]
Public Alert No. 037/2024 – Alert on Confirmed Counterfeit of Mabthera 500mg/50ml in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeit of Mabthera 500mg/50ml with batch number N7458B07 in Nigeria. The Marketing Authorization Holder (MAH) Roche received a call from a patient to enquire the genuineness of the product before purchasing it. […]
Public Alert No. 036/2024 – Sale and Distribution of Unregistered/Banned Veterinary Products
The National Agency for Food and Drug Administration and Control (NAFDAC) wishes to inform the public about the distribution and sales of unregistered veterinary drugs and veterinary drugs banned for use in food-producing animals. Following a report received from the Veterinary Medicines and Allied Products (VMAP) Directorate, some establishments listed below have been identified to […]
Public Alert No. 035/2024 – Alert on the Recall of Dove Beauty Cream Bar Soap due to Butyphenyl Methylpropional (BMHCA) content
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the recall of Dove Beauty Cream Bar Soap (100g) with batch number 81832M 08, produced in Germany, due to chemical impurity. The product does not comply with the Cosmetic Products Regulation as it is said to contain Butylphenyl Methylpropional […]
Public Alert No. 034/2024 – Philippines Authority Warns Against the Purchase and Use of Some Unregistered Drug Products in Philippines
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the Philippines Food and Drug Administration (FDA) has warned against the purchase and use of the five unregistered drug products namely: Niaosu Ruangao, Compound Bismuth Subnitrate Tablets, Cimetidine Injection 2ml:0.2g Ampoule, OTC Dextromethorphan Hydrobromide Syrups, Jingxin Pharmceutical Roxithromycin Capsules […]
